🦊/Investors

Curie Capital

Venture capital

Amsterdam · Seed–Series A · 8 people tracked

Find your way into Curie Capital

1,932 people in our graph share verified history with the Curie Capital team — schools, employers, funds. One of them is your warm intro.

René Kuijtenunlockedknows Mirjam Mol-Arts · together at Utrecht University (overlapped)
×3knows the team · via Stealth Startup
×2knows the team · via Included VC
knows the team · via NV Organon
knows the team · via Medicxi
knows the team · via Vrije Universiteit Amsterdam (VU Amsterdam)
Fox Verdict
Sign up to see your fit

Investment thesis

Curie Capital backs early-stage Life Sciences companies, investing at Seed and Series A stages in biotechnology, pharmaceutical, and medical technology firms typically focused on therapeutics, diagnostics, or class IIb and III medical devices. The firm typically leads rounds and syndicates alongside experienced co-investors, supporting portfolio companies with hands-on operational expertise and network access. Under its current fund (Curie Capital 3), it complies with RVO seed capital regulations and invests only in companies with a Dutch headquarters that have not raised more than €3.5 million in equity and/or convertible loans.

Source: firm website, verified Aug 3, 2026.

Stage
Seed–Series A
HQ
Amsterdam, NL
Leads rounds
Leads
Instruments
Equity
Founded
2018
Tracked investments
7

Team · 8 people

from the firm's website & public directories
Olivier Tak· Junior Partnerin

Junior Partner at Curie Capital, holds an MD.

Helmuth van Es· Advisory Committee memberin

Advisory Committee member and seasoned biotech leader; holds a PhD.

Markwin Velders· Advisory Committee memberin

Advisory Committee member and seasoned biotech leader; holds a PhD.

Minh Thu Nguyen· Fellowin

Fellow at Curie Capital.

Mirjam Mol-Arts· Advisory Committee memberin

Advisory Committee member and seasoned biotech leader; holds an MD.

What they invest in

from 7 of 7 portfolio companies

Biotech ×6Healthtech ×5Medical Devices ×5AI & Machine Learning ×1Deep Tech ×1Digital Health ×1Hardware ×1Longevity ×1

HQs:Netherlands×5

Investments · 7 tracked

founders shown can be your intro path
Allerotherapeuticsallerotherapeutics.com

Allero Therapeutics is a biotech company focused on immunotherapy solutions for allergy and immune-mediated disorders, particularly Celiac Disease.

BiotechHealthtechMedical Devices

Emil Pot(CEO)Federico Grego(CFO)Poul Sørensen(CSO)in

Avidicureavidicure.com

Avidicure develops "Actibody", a triple-agonistic antibody platform built on a human IgG scaffold designed to activate the innate and adaptive immune system for treating oncology and autoimmune diseases.

AI & Machine LearningBiotech

Robert Friesen(Founder)in

Co-investorsBioGeneration VenturesEQT Life SciencesBOMKurma PartnersV-Bio Ventures

Citryllcitryll.comin

Citryll is a clinical-stage biotech developing CIT-013, an antibody therapy that targets extracellular traps by selectively binding citrullinated histones to both inhibit new trap formation and clear existing ones.

BiotechHealthtechMedical DevicesOss, NL

Renato Chirivi(Co-founder (former CSO))in

BoardPaul Peter Tak(Chair of the Board)

Co-investorsPureos BioventuresBioGeneration VenturesForbionJohnson & Johnson Innovation – JJDCSeventure PartnersBOM+1 more

Clearaclearabiotech.comin𝕏

Cleara Biotech develops compounds to eliminate senescent cells for treating late-stage cancer and chronic age-related diseases.

BiotechDeep TechHealthtechLongevityMedical DevicesUtrecht, NL

Peter de Keizer(Founder and Managing Director)inTobias Madl(Head of Structural Biology, Scientific Co-founder)

Co-investorsCoastCapKorify CapitalApollo Health VenturesKurma PartnersROM Utrecht Region

Laigo Biolaigobio.comin

Laigo Bio develops targeted protein degradation therapies using its SureTACs (Surface Removal Targeting Chimeras) platform, which uses bispecific antibodies to direct cell-surface proteins toward lysosomal degradation via membrane-bound E3 ligases.

BiotechHealthtech

Co-investorsAngelini VenturesKurma Partners

Siriussirius-medical.comin𝕏

Sirius Medical develops surgical devices for precise breast cancer tumor localization and removal.

Digital HealthHardwareHealthtechMedical DevicesAmsterdam, NL

Netherlands Cancer Institute

Co-investorsBOMRotrip

TargED Biopharmaceuticalstargedbiopharmaceuticals.cominFeb 2022

TargED is a biopharmaceutical company developing therapeutics for thrombotic disorders, spun out from University Medical Center Utrecht.

BiotechMedical DevicesUtrecht, NL

Coen Maas(Co-founder)inSteven de Maat(Chief Scientific Officer)inMarc van Moorsel(Director of Operations)inKristof Vercruysse(Chief Executive Officer)inRob Dekker(Vice President CMC)inFilip Van den Wyngaert(Vice President Asset Management)in

Co-investorsAndera PartnersFund+Hadean VenturesRotripBioGeneration VenturesInkef+1 more

Portfolio news

latest coverage across their companies

Frequently asked questions

How many investments has Curie Capital made?
Curie Capital has 7 tracked investments.
What stage does Curie Capital invest at?
Curie Capital invests at the Seed, Series A stages.
What sectors does Curie Capital focus on?
Curie Capital focuses on Biotech, Digital Health, Healthtech, Medical Devices.
Where is Curie Capital located?
Curie Capital is headquartered in Amsterdam, NL.
Does Curie Capital lead rounds?
Yes, Curie Capital leads investment rounds.
Who does Curie Capital co-invest with?
Curie Capital most often shares deals with BOM, Kurma Partners, Rotrip, among 12 tracked co-investors.

Images

Curie Capital photo

Similar investors

Featured in lists